Changes in Neurologic Function Tests May Predict Neurotoxicity Caused by Ixabepilone From October 2000 to April 2002, 547 patients from 51 institutions were entered onto the trial. The average age was ...
The objective of this review is to summarize the use of Omegaven (Fresenius-Kabi, Bad Homburg, Germany) in treating PN-associated cholestasis (PNAC) and PNALD in infants. Omegaven is a 10% fish-oil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results